Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-31

FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for tolmetin sodium from Atland Pharmaceuticals, LLC. This action approves changes under an approved ANDA for the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tolmetin sodium (Tolmetin sodium)

Snippet

SUPPL AP for TOLMETIN SODIUM (TOLMETIN SODIUM)